This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

What are the implications and transferability of this study?

Prescribing Information

Prospective evaluation of the cost of diagnosis and treatment of invasive fungal disease in a cohort of haematology patients in the UK

Mansour Ceesay, Consultant Haematologist, King’s College Hospital, NHS Foundation Trust

Length: 04:27

Questions addressed:

  • So what have you done differently at King’s College Hospital as a result of this study?
  • In your opinion are the results of this study transferable?

The study discussed in this video was supported by Gilead Sciences, Pfizer and Merck Sharp & Dohme (MSD) Limited who provided unrestricted educational grants for the project.

This study was published in the Journal of Antimicrobial Chemotherapy Volume 70, Issue 4, April 2015, pp. 1175– 1181.

More information about NOXAFIL® (posaconazole)